Treace Medical Concepts Inc Market Cap ($227.70 Million)
Market Cap & Net Worth: Treace Medical Concepts Inc (TMCI)
Treace Medical Concepts Inc market cap. Treace Medical Concepts Inc (NASDAQ:TMCI) has a market capitalization of $227.70 Million ($227.70 Million) as of November 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #15839 globally and #3782 in its home market, demonstrating a -3.17% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Treace Medical Concepts Inc's stock price $4.28 by its total outstanding shares 64872976 (64.87 Million). Also see cash flow conversion of Treace Medical Concepts Inc for how efficiently the company converts equity into cash flow.
Treace Medical Concepts Inc Market Cap History (2021–2026)
Treace Medical Concepts Inc market cap history from 2021 to 2026. Data shows change from $1.21 Billion to $277.66 Million (-27.58% CAGR). Check Treace Medical Concepts Inc (TMCI) stock price for real-time trading data and today's change.
Index Memberships
Treace Medical Concepts Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.61 Trillion | 0.01% | #424 of 976 |
|
NASDAQ Composite
IXIC
|
$40.20 Trillion | 0.00% | #1551 of 3165 |
Weight: Treace Medical Concepts Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Treace Medical Concepts Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Treace Medical Concepts Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Treace Medical Concepts Inc net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.75x
Treace Medical Concepts Inc's market cap is 0.75 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $1.21 Billion | $94.42 Million | -$20.55 Million | 12.81x | N/A |
| 2022 | $1.49 Billion | $141.84 Million | -$42.81 Million | 10.52x | N/A |
| 2023 | $827.13 Million | $187.12 Million | -$49.53 Million | 4.42x | N/A |
| 2024 | $482.65 Million | $209.36 Million | -$55.74 Million | 2.31x | N/A |
| 2025 | $158.94 Million | $212.69 Million | -$59.00 Million | 0.75x | N/A |
Competitor Companies of TMCI by Market Capitalization
Companies near Treace Medical Concepts Inc in the global market cap rankings as of November 4, 2026. Also see Treace Medical Concepts Inc asset portfolio for a full breakdown of the balance sheet.
Key companies related to Treace Medical Concepts Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #110 globally with a market cap of $190.23 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #204 globally with a market cap of $119.12 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #226 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #110 | Abbott Laboratories | NYSE:ABT | $190.23 Billion | $109.40 |
| #204 | Stryker Corporation | NYSE:SYK | $119.12 Billion | $310.55 |
| #226 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $98.88 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Treace Medical Concepts Inc (2021–2026)
Market capitalization of Treace Medical Concepts Inc from 2021 to today. Between 2021 and today, Treace Medical Concepts Inc's market cap moved from $1.21 Billion to $ 277.66 Million, with a yearly change of -27.58%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $277.66 Million | +74.69% |
| 2025 | $158.94 Million | -67.07% |
| 2024 | $482.65 Million | -41.65% |
| 2023 | $827.13 Million | -44.54% |
| 2022 | $1.49 Billion | +23.34% |
| 2021 | $1.21 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Treace Medical Concepts Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $227.70 Million USD |
| MoneyControl | $227.70 Million USD |
| MarketWatch | $227.70 Million USD |
| marketcap.company | $227.70 Million USD |
| Reuters | $227.70 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Treace Medical Concepts Inc
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D M… Read more